Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Nidan Laboratories And Healthcare Ltd
Your Vote -
Buy
87.50%
Hold
0.00%
Sell
12.50%
87.50%
8 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
19.15
3000
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
3000
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Nidan Laboratories And Healthcare Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Nidan Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025
-
Nidan Laboratories - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Nidan Laboratories - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
-
Nidan Laboratories - Trading Window
-
Nidan Laboratories - Shareholders meeting
-
Nidan Laboratories - Shareholders meeting
-
Nidan Laboratories - Shareholders meeting
-
Nidan Laboratories - Copy of Newspaper Publication
Key fundamentals
Evaluate the intrinsic value of Nidan Laboratories And Healthcare Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 79.2935 | 78.6407 | 80.3683 | 85.1936 | 51.3766 |
| Liabilities | 79.2935 | 78.6407 | 80.3683 | 85.1936 | 51.3766 |
| Equity | 13.9 | 13.9 | 13.9 | 13.9 | 9.9 |
| Gross Profit | 5.062 | 6.4442 | 6.8036 | 9.4137 | 8.8869 |
| Net Profit | 1.9769 | -3.2323 | 3.5396 | 2.6629 | 2.3024 |
| Cash From Operating Activities | 2.2764 | -14.9259 | 13.8958 | 7.8274 | 4.3452 |
| NPM(%) | 8.05 | -13.36 | 14.58 | 8.97 | 11.29 |
| Revenue | 24.5275 | 24.1774 | 24.2659 | 29.6601 | 20.3775 |
| Expenses | 19.4655 | 17.7332 | 17.4623 | 20.2464 | 11.4906 |
| ROE(%) | 2.89 | -4.74 | 5.19 | 3.9 | 3.37 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Nidan Laboratories And Healthcare Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 883.05 | 3.90 | 80.06 | 0.00 | 301.39 | 0.57 |
| Lotus Eye Hospital and Institute Ltd | 131.17 | 4.91 | 423.13 | 0.00 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 10.00 | -0.40 | 333.33 | 0.00 | 3.13 | 0.00 |
| Astec Lifesciences Ltd | 672.25 | 1.85 | 0.00 | 0.00 | -604.77 | 0.00 |
Company Info
The Company was originally incorporated as Abhi Diagnostic Imagings Private Limited on December 05, 2000 under the Companies Act, 1956 vide certificate of incorporation issued by the Registrar of Companies, Maharashtra. Subsequently, the name of the company was changed from "Abhi Diagnostic Imagings Private Limited" to "Nidan Laboratories And Healthcare Private Limited" under the Companies Act, 2013 pursuant to a special resolution passed by the shareholders at the EGM held on February 26, 2021 and had obtained fresh certificate of incorporation dated March 24, 2021 issued by the Registrar of Companies, Maharashtra. Subsequently, the Company was converted into a public limited company and the name of the Company was changed to `Nidan Laboratories And Healthcare Limited' and a fresh certificate of incorporation consequent upon conversion to public limited company was issued by the Registrar of Companies, Mumbai, Maharashtra, on May 24, 2021. The CIN of the Company is U33111MH2000PLC129883.Major Events and Milestones :2019- Nidan has received Best Chain of Diagnostic award 2019 By Express Health care by Division of Express Healthcare2021- Dr. Nitin Thorve Promoter has done extensive work during Covid 19
The Company was originally incorporated as Abhi Diagnostic Imagings Private Limited on December 05, 2000 under the Companies Act, 1956 vide certificate of incorporation issued by the Registrar of Companies, Maharashtra. Subsequently, the name of the company was changed from "Abhi Diagnostic Imagings Private Limited" to "Nidan Laboratories And Healthcare Private Limited" under the Companies Act, 2013 pursuant to a special resolution passed by the shareholders at the EGM held on February 26, 2021 and had obtained fresh certificate of incorporation dated March 24, 2021 issued by the Registrar of Companies, Maharashtra. Subsequently, the Company was converted into a public limited company and the name of the Company was changed to `Nidan Laboratories And Healthcare Limited' and a fresh certificate of incorporation consequent upon conversion to public limited company was issued by the Registrar of Companies, Mumbai, Maharashtra, on May 24, 2021. The CIN of the Company is U33111MH2000PLC129883.Major Events and Milestones :2019- Nidan has received Best Chain of Diagnostic award 2019 By Express Health care by Division of Express Healthcare2021- Dr. Nitin Thorve Promoter has done extensive work during Covid 19
Read More
Parent Organisation
Nidan Laboratories And Healthcare Ltd.
Founded
05/12/2000
Managing Director
NSE Symbol
NIDANSM
FAQ
The current price of Nidan Laboratories And Healthcare Ltd is
The 52-week high for Nidan Laboratories And Healthcare Ltd is
The market capitalization of Nidan Laboratories And Healthcare Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Nidan Laboratories And Healthcare Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Nidan Laboratories And Healthcare Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Nidan Laboratories And Healthcare Ltd shares.
The CEO of Nidan Laboratories And Healthcare Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
